SEPTInvestingStart Free

QNCX SCHEDULE 13G: SEC filing

SilverArc Capital Management, LLC

Filed with the SEC on · accession 0001104659-26-127344

QNCX filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 13, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

SilverArc Capital Management, LLC filed a Schedule 13G disclosing beneficial ownership of 880,255 shares (7.9%) of IRulya Therapeutics Inc., including 586,836 common shares and 293,419 exercisable warrants, as a passive investor.

For details, click here →

Key details

Total beneficial ownership shares$880K
Common stock shares held$587K
Exercisable warrants held$293K
Reporting person / beneficial ownerSilverArc Capital Management, LLC
IssuerIRulya Therapeutics Inc.
Sole member of silverarc capital management, llcDevesh Gandhi

✦ Ask GOAX AI about this filing — what it means for QNCX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for QNCX?

Click here

Frequently asked questions

What did QNCX file with the SEC on Nov 13, 2026?

QNCX filed a SCHEDULE 13G (SEC filing). SilverArc Capital Management, LLC filed a Schedule 13G disclosing beneficial ownership of 880,255 shares (7.9%) of IRulya Therapeutics Inc., including 586,836 common shares and 293,419 exercisable warrants, as a passive investor.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

Other QNCX SEC filings

Get alerts when QNCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
QNCX overviewQNCX analysisQNCX newsLatest SEC filings